F-group (family)
158.1.1.1 Lipoxygenase
Ligands and drugs
306
Member domains
165
with ligand contacts (≤ 4 Å)
53.9% of members
144
with DrugDomain annotations
47.1% of members
56
with a DrugBank compound
18.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 158.1.1.1 belongs to X-group 158 Lipoxygenase, which has 19 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04557 | ACD | Arachidonic Acid | 12 |
| DB18307 | ZR5 | VLX-1005 | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 4 |
| DB08492 | RS7 | (2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID | 3 |
| DB02159 | PGR | (R)-Propylene glycol | 2 |
| DB02709 | — | Resveratrol | 2 |
| DB03175 | POL | Propyl alcohol | 2 |
| DB00159 | — | Icosapent | 1 |
| DB00163 | — | Vitamin E | 1 |
| DB00179 | — | — | 1 |
| DB00233 | — | Aminosalicylic acid | 1 |
| DB00244 | — | — | 1 |
| DB00471 | — | Montelukast | 1 |
| DB00711 | — | — | 1 |
| DB00744 | — | — | 1 |
| DB00795 | — | Sulfasalazine | 1 |
| DB00939 | — | Meclofenamic acid | 1 |
| DB01014 | — | — | 1 |
| DB01017 | — | Minocycline | 1 |
| DB01892 | — | Hyperforin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FE2metal | FE (II) ION | 96 |
| FEmetal | FE (III) ION | 48 |
| CL | CHLORIDE ION | 19 |
| CAmetal | CALCIUM ION | 16 |
| ACD | ARACHIDONIC ACID | 12 |
| CDmetal | CADMIUM ION | 12 |
| MNmetal | MANGANESE (II) ION | 9 |
| ZR5 | N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide | 6 |
| ZPE | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradec-5-enoyloxy)propyl (11Z)-octadec-11-enoate | 5 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 4 |
| OYP | 3-{4-[(tridec-2-yn-1-yloxy)methyl]phenyl}propanoic acid | 4 |
| NAmetal | SODIUM ION | 3 |
| 3VV | S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (9Z)-octadec-9-enethioate (non-preferred name) | 2 |
| Kmetal | POTASSIUM ION | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| PDO | 1,3-PROPANDIOL | 2 |
| PGR | R-1,2-PROPANEDIOL | 2 |
| POL | N-PROPANOL | 2 |
| PQE | 3,6,12,15,18,21,24-HEPTAOXAHEXATRIACONTAN-1-OL | 2 |
| RS7 | (2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID | 2 |